SwanBio Therapeutics raised $56M Series B venture round, led by Mass General Brigham Ventures.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Private | — | |
SynconaLEAD | Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$108M
Top Valuation
-
SwanBio Therapeutics raised $56M in a Series B round.
The round was announced on 05/18/22.
The round was led by Mass General Brigham Ventures, Chris Hollowood.